These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2142686)

  • 1. Specific suppression of heterotropic interactions in phosphofructokinase by the mutation of leucine 178 into tryptophan.
    Serre MC; Teschner W; Garel JR
    J Biol Chem; 1990 Jul; 265(21):12146-8. PubMed ID: 2142686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
    Le Bras G; Garel JR
    Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the C-terminal region in the allosteric properties of Escherichia coli phosphofructokinase-1.
    Serre MC; Garel JR
    Eur J Biochem; 1990 May; 189(3):487-92. PubMed ID: 2140983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli.
    Auzat I; Gawlita E; Garel JR
    J Mol Biol; 1995 Jun; 249(2):478-92. PubMed ID: 7783204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis identifies catalytic residues in the active site of Escherichia coli phosphofructokinase.
    Berger SA; Evans PR
    Biochemistry; 1992 Sep; 31(38):9237-42. PubMed ID: 1390710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of allosteric inhibition to activation in phosphofructokinase by protein engineering.
    Lau FT; Fersht AR
    Nature; 1987 Apr 23-29; 326(6115):811-2. PubMed ID: 2952886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric activation increases the maximum velocity of E. coli phosphofructokinase.
    Auzat I; Le Bras G; Garel JR
    J Mol Biol; 1997 Apr; 267(3):476-80. PubMed ID: 9126831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of the phosphofructokinase from Lactobacillus bulgaricus. A non-allosteric analog of the enzyme from Escherichia coli.
    Le Bras G; Deville-Bonne D; Garel JR
    Eur J Biochem; 1991 Jun; 198(3):683-7. PubMed ID: 1828763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of the effector-binding site and complementation studies of Escherichia coli phosphofructokinase using site-directed mutagenesis.
    Lau FT; Fersht AR
    Biochemistry; 1989 Aug; 28(17):6841-7. PubMed ID: 2531002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing an allosterically locked phosphofructokinase.
    Kundrot CE; Evans PR
    Biochemistry; 1991 Feb; 30(6):1478-84. PubMed ID: 1825177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conformational transition involved in antagonistic substrate binding to the allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Garel JR
    Biochemistry; 1992 Feb; 31(6):1695-700. PubMed ID: 1531298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active-site mutants altering the cooperativity of E. coli phosphofructokinase.
    Berger SA; Evans PR
    Nature; 1990 Feb; 343(6258):575-6. PubMed ID: 2137204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expanded two-state model accounts for homotropic cooperativity in biosynthetic threonine deaminase from Escherichia coli.
    Eisenstein E; Yu HD; Fisher KE; Iacuzio DA; Ducote KR; Schwarz FP
    Biochemistry; 1995 Jul; 34(29):9403-12. PubMed ID: 7626610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction by site-directed mutagenesis of a tryptophan residue as a fluorescent probe for the folding of Escherichia coli phosphofructokinase.
    Teschner W; Serre MC; Garel JR
    Biochimie; 1990; 72(6-7):403-6. PubMed ID: 2147862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a single activating allosteric interaction in phosphofructokinase from Escherichia coli.
    Fenton AW; Reinhart GD
    Biochemistry; 2002 Nov; 41(45):13410-6. PubMed ID: 12416986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis in the effector site of Escherichia coli phosphofructokinase.
    Lau FT; Fersht AR; Hellinga HW; Evans PR
    Biochemistry; 1987 Jun; 26(13):4143-8. PubMed ID: 2958087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equilibrium binding studies of a tryptophan-shifted mutant of phosphofructokinase from Bacillus stearothermophilus.
    Riley-Lovingshimer MR; Reinhart GD
    Biochemistry; 2001 Mar; 40(9):3002-8. PubMed ID: 11258913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-steady state quantification of the allosteric influence of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    J Biol Chem; 2001 Sep; 276(37):34388-95. PubMed ID: 11443117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.
    Auzat I; Le Bras G; Garel JR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5242-6. PubMed ID: 8202475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.